Nelfinavir Main Page

Medical Advocates
Nelfinavir (Viracept)

Main Page

New/Noteworthy
Database of ARV Drug Interactions
Guidelines
Journal Data
Conference Data
Perinatal Index
Pediatric Index
Protease Inhibitors: General Data
Therapeutic Drug Monitoring
Viracept Labeling

ARV Drugs Main Page Main New/Newsworthy Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: June 30, 2009
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Perinatal data are integrated in the Perinatal Data Page.
Pediatric data are integrated with Pediatric Conference Data in the Pediatric Data Page

New and Noteworthy

June 2009

Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization
that can be overcome by sorafenib.
Brüning A, Burger P, Vogel M, et al Invest New Drugs. 2009 Jun 26

Clinicians' Knowledge of 2007 Food and Drug Administration Recommendation to Discontinue Nelfinavir
Use During Pregnancy.
Fogler J, Weber S, Mahoney MR, Goldschmidt RH. J Int Assoc Physicians AIDS Care (Chic Ill). 2009 Jun 8.

May 2009

Nelfinavir+M8 Plasma Levels Determined with an ELISA Test in HIV Infected Patients with or without
HCV and/or HBV Coinfection: The VIRAKINETICS II Study.
Uglietti A, Ravasi G, Meroni V, Narciso P, et al Curr HIV Res. 2009 May;7(3):293-301

The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients.
Crum-Cianflone NF, Hullsiek KH, Marconi V, et al J Acquir Immune Defic Syndr. 2009 Apr 29

ARV Drugs Main Page Main New/Newsworthy Home Page

Nelfinavir Main Page